FDA Cybersecurity Guidelines for Medical Devices: A Complete Guide 

Connected medical devices are now part of everyday healthcare infrastructure. Infusion pumps, imaging systems, patient monitors, wearable devices, and AI-based diagnostic tools often depend on software, hospital networks, cloud platforms, APIs, and wireless communication. This makes compliance with FDA cybersecurity guidelines increasingly important.

That connectivity has made device security a direct patient safety issue. RunSafe Security reported that 24% of healthcare organizations experienced cyberattacks affecting medical devices, and 80% of those incidents had an impact on patient care. The FDA has also tightened its expectations. Its latest guidance addresses cybersecurity in medical device quality systems and premarket submissions, including Section 524B requirements for cyber devices.

For manufacturers, the concern is no longer only whether a device works as designed. It is also whether the device can remain safe and reliable when exposed to real cyber risks. This guide explains what the FDA expects and how manufacturers can prepare.

Evolving Medical Device Cybersecurity Landscape

As wireless, internet, and network-connected features become more integrated, along with portable media like USBs or CDs and the frequent technological transfer of health data related to medical devices, strong cybersecurity measures have become increasingly necessary to ensure the safety and efficacy of medical devices. The FDA Cybersecurity Guidelines highlight the need to protect medical devices from vulnerabilities to keep patients safe and devices functional. Additionally, due to the increased frequency and intensity of cybersecurity assaults directed at the healthcare industry, there is a higher chance of clinical repercussions.  

The provision of patient care at healthcare institutions across the United States and the world has been hampered by cybersecurity breaches that have led to the failure of hospital networks and medical devices. As a result of these cyberattacks and vulnerabilities, clinical hazards, like delays in diagnosis and/or treatment, could harm patients. 

Due to growing interconnection, specific devices are now functioning as separate components of bigger healthcare systems. These systems may consist of application update machines, other devices, connections of medical centers, and other interconnected components. A breach of FDA cybersecurity can therefore jeopardize a device’s safety and efficacy by impairing the operation of any system component if proper cybersecurity considerations are not given to all facets of these systems. Therefore, proper device cybersecurity and system-wide security are essential to guarantee device efficacy and safety.  

What is the FDA and How Does It Regulate Medical Devices?

The Food and Drug Administration (FDA) is a federal agency of the United States Department of Health and Human Services that is responsible for safeguarding the general public by guaranteeing the security, reliability, and efficacy of both human and veterinary pharmaceuticals, biological compounds, and surgical instruments. It also regulates the country’s diet, beauty products, and radiation-emitting goods. 

How Does the FDA Regulate Medical Devices?  

The FDA is responsible for monitoring the development, production, marketing, and subsequent monitoring of healthcare products, ensuring that they meet rigorous safety and efficacy standards, including FDA Cybersecurity Guidelines. As the oldest consumer protection organization in the United States, the FDA sets some of the most stringent quality requirements globally.

The FDA utilizes an administrative structure to classify healthcare products according to the danger they pose to the user or patient. The least amount of regulation is applied to the first-class devices, which are thought to present the least amount of danger. Due to their increased risk, second-generation devices need more scrutiny from regulators to give a fair guarantee of their efficacy and safety. FDA medical device cybersecurity devices that fall under Class III are thought to be the most dangerous and typically need preliminary market authorization (PMA), which is an academic assessment that guarantees the device’s effectiveness and security.  

Modern connected devices of all classes have to fulfill particular FDA-revised “Cyber Device” requirements, even if device classes help to define overall regulatory examination.

Request FDA Compliance Assessment Today!

What Are FDA Cybersecurity Guidelines 

FDA cybersecurity guidelines explain what medical device companies need to show before connected devices reach the market. For cyber devices, the FDA expects proof that security risks have been reviewed, software components are listed, vulnerabilities can be handled, and updates can be provided after release. 

Additional FDA Guidance for Networked Medical Devices

Key Updates in the Guidelines: 

Although the layout and product of the updated FDA cybersecurity guidelines for medical devices are identical to those of the prior version, the security risk control part now includes two more significant sections:  

• The exact data components that are required to be included in premarket entries will also be included in a separate annex for IDE filings.  

• There are several cybersecurity word definitions.  

Premarket Submissions and Cybersecurity Risk Reports:

According to the FDA Cybersecurity Guide for the year 2023, a security risk report by management should be included in a submission for premarket approval to help demonstrate the efficacy and safety of the product.  

Cybersecurity Risk Assessments:

The initial part of the two new sections on “Cybersecurity Risk Assessments” is part of the updated cybersecurity risk management section of the instructions. The recommendation recognizes that risks related to cybersecurity are hard to predict and that the likelihood of a breach happening may not be estimated or quantified using past information or simulation.

By defining the content required for premarket paperwork, these guidelines make sure that companies provide sufficient evidence of their cybersecurity risk management plans. This includes a cybercrime risk management strategy for the device as well as documentation of medical device cybersecurity risk assessments, security controls, and outcomes of testing. 

An SBOM (Software Bill of Materials) that contains an in-depth list of all software components used in a device for healthcare, which includes those created by the manufacturer and those created by other companies, is what the FDA cybersecurity compliance is requesting. An SBOM facilitates risk management procedures by assisting users and device manufacturers in promptly identifying possible safety risks. 

What Is a Cyber Device Under FDA Section 524B Rules?

Under Section 524B, the FDA defines a “cyber device” as a medical device that includes software, connects to the internet or other networks, and contains vulnerabilities that cyber threats could exploit.

A device typically falls under this category if it:

• Uses software or programmable technology
• Connects through networks or external systems
• Can face cybersecurity risks that affect safety or performance

The FDA also considers indirect connectivity when evaluating devices. This includes Bluetooth, Wi Fi, USB connections, cloud integrations, and remote servicing interfaces.

Common examples of covered devices include:

• Insulin pumps
• Infusion systems
• AI diagnostic platforms
• Wearable medical devices
• Robotic surgery systems
• Patient monitoring equipment

How Has Medical Device Cybersecurity Become a Patient Safety Priority?

Medical device cybersecurity now sits close to patient safety because connected devices are used during real care, not only for record keeping. A monitor can guide a nurse’s next action. An infusion pump can control how much medication enters a patient’s body. An imaging system can affect diagnosis. If any of these devices fail, freeze, display wrong data, or respond to an unauthorized command, the problem can reach the patient very quickly.

The FDA has made this point clear in its medical device cybersecurity guidance. Connected devices bring clinical benefits, but internet access, hospital networks, wireless links, and software components also create security risks that may affect device safety and performance. The FDA also says manufacturers and healthcare facilities both have a role in reducing those risks.

Real FDA safety alerts show the concern is not theoretical. The FDA has warned about monitor vulnerabilities that could allow:

• Device crashes
• Remote control
• Corrupted data
• Insulin pump communication flaws that could affect insulin delivery

Protect your regulated data before FDA inspectors find the gaps.

 

Regulatory approval starts with cybersecurity readiness. Validate your device before submission.

👨‍⚕️ Talk to a Medical Device Expert →

 

FDA Secure Product Development Framework (SPDF)

The FDA endorses the creation and application of a “Secure Product Development Framework,” or “SPDF,”. This is defined as a set of actions that reduce the quantity and seriousness of manufacturing flaws throughout its duration. 

Three key components are emphasized in the SPDF, which is intended to be the fundamental framework for managing cybersecurity threats, and they are Security Risk Management, Security Architecture, and Cybersecurity Testing. 

The health software reference standard IEC 81001-5-1 is also mentioned in the manual as an excellent structure to look into while creating the SPDF.

Why SPDF Became Central to FDA Cybersecurity Reviews

The FDA now expects medical device companies to think about cybersecurity from the very beginning of product development. Security can no longer be added at the final stage before submission.

To support this approach, the FDA recommends using a Secure Product Development Framework as part of the Quality Management System. This helps manufacturers build devices with security in mind throughout the entire lifecycle, from design and development to updates and postmarket maintenance.

An effective SPDF also helps companies create consistent security processes, manage vulnerabilities over time, and maintain clear traceability for security-related decisions and changes.

1. Security by Design Requirements

Build cybersecurity into medical devices from the beginning. Adding security controls after development is no longer enough for compliance or patient safety.

Security should be considered during:

• Architecture planning
• Requirement gathering
• Software design
• Component and third-party technology selection

The FDA also encourages companies to follow secure design principles such as least privilege access and secure default configurations. These measures help reduce attack surfaces and limit the impact of potential cyber threats.

2. Threat Modeling Expectations

Manufacturers should perform formal threat modeling as part of the medical device security process. This helps identify possible attack paths before the product enters real healthcare environments.

Companies often use methods such as:

• STRIDE
• Attack trees
• Abuse case analysis
• MITRE ATT&CK mapping

A proper threat model should clearly document critical security areas, including trust boundaries, attack surfaces, privilege escalation paths, attacker profiles, and data flow analysis.

3. Secure Coding Practices

The FDA expects security to be part of the coding process, not something you fix later when the product is almost ready. One weak function or outdated library can open the door to serious security problems in connected medical devices.

That is why many medical device teams follow coding standards like OWASP, MISRA, and CERT Secure Coding while building software. Developers usually focus on things like:

• Checking and filtering user input properly
• Preventing memory-related issues
• Strengthening login and authentication controls
• Reviewing third-party libraries before using them

The FDA also expects these security checks to stay part of the development lifecycle instead of being treated as a last-minute task.

4. Security Testing Requirements

Medical device software needs more than regular quality testing. Companies must check how the device reacts to real security threats before it reaches hospitals or patients.

This usually includes:

• Static analysis for insecure code
• Dynamic analysis during runtime
• Fuzz testing with unexpected inputs
• Penetration testing to uncover attack paths
• Vulnerability scanning for known security flaws

Testing should happen in production-like environments because isolated lab setups often miss real-world risks.

Cybersecurity Documentation Required by FDA

FDA cybersecurity review depends on evidence. For cyber devices, Section 524B asks sponsors to submit postmarket vulnerability plans, patch and update processes, and an SBOM. FDA’s premarket guidance also expects records that show how security was handled during design, testing, risk review, and maintenance.

1. Penetration Testing Reports

A penetration testing report shows how the device was tested from an attacker’s view. It should cover the test scope, methods used, vulnerabilities found, severity, exploitation evidence, remediation status, and retest results.

2. Cybersecurity Risk Assessment

This document connects security weaknesses with possible harm. It should explain what can go wrong, how it may affect the device or patient safety, which controls reduce the risk, and what risk remains after mitigation.

3. Threat Modeling Reports

A threat model shows how someone could attack the device. It should map entry points, data flows, trust boundaries, user roles, connected systems, and likely attack paths before the product reaches real users.

4. Security Architecture Documentation

Security architecture records explain how the device is built and protected. These may include diagrams for software, hardware, APIs, cloud systems, network connections, remote access, update channels, and security controls.

5. Secure Product Development Framework Evidence

SPDF evidence proves that security was part of development work from the start. It can include security requirements, secure coding records, design reviews, code reviews, test records, and links between risks and controls. FDA recommends using an SPDF for devices with cybersecurity risk.

6. Vulnerability Management Plan

This plan shows how the manufacturer will handle security flaws after release. It should cover:

• Vulnerability intake
• Triage
• Severity rating
• Fixes
• Retesting
• Disclosure
• Customer communication
• Timelines for action.

7. SBOM

An SBOM lists the software components inside the device, including commercial, open-source, and off-the-shelf software. It helps teams check whether a newly reported software flaw affects the device. Section 524B requires an SBOM for cyber devices.

8. Patch Management Procedures

Patch procedures explain how security fixes will be created, tested, approved, released, and tracked. The FDA expects manufacturers to make postmarket updates and patches available when needed.

9. Incident Response Plan

An incident response plan sets out what happens when a cybersecurity event affects the device or related systems. It should cover:

• Investigation
• Containment
• Recovery
• Internal roles
• Customer notices
• Regulatory reporting
• Follow-up fixes.

10. Access Control and Authentication Documentation

This documentation shows who can access the device and what each user can do. It should cover clinical users, admins, service teams, remote support, APIs, password rules, session limits, MFA where used, and role-based permissions.

11. Encryption Implementation Details

Encryption records show how sensitive data is protected. They should explain encryption for stored data, secure data transfer, certificate handling, key storage, key rotation, and secure communication between the device and connected systems.

12. Postmarket Surveillance Procedures

Postmarket surveillance procedures show how the manufacturer keeps checking for new cyber risks after launch. This includes CVE tracking, SBOM checks, researcher reports, exploit monitoring, customer feedback, patch follow-up, and verification after fixes.

Need a Real Penetration Testing Report Sample Today?

See exactly how security experts document vulnerabilities, risks, and remediation steps in a professional pentest report.

Download Sample Report →

The FDA’s Cybersecurity Requirements for Medical Devices  

Unlike various facets of the manufacturing process, assessment is used to demonstrate the effectiveness of control mechanisms. Cybersecurity regulations require a test that goes beyond typical software validation and verification tasks, notwithstanding the intimate relationship between the creation of software and cybercrime. This is necessary to illustrate the measures’ efficacy within an appropriate safety framework. This proves that the product’s efficiency and security are reasonably guaranteed. 

It is necessary for an organization to establish and uphold procedures for verifying its device layout. This check must guarantee that the design result meets the design input’s requirements. To certify the design of a device, its maker must set up and uphold procedures. Validation of software and risk assessments must be included in the validation of designs where applicable. 

The FDA suggests that sufficient examination of the maker’s inputs and findings, if any, and additionally, the cybersecurity requirements for medical devices should be part of the verification and endorsement process. The premarket filing should contain security testing documentation along with any related conclusions or assessments. 

Several types of tests are recommended to be included in the submission, among other things, by the FDA cybersecurity guidance for the year 2023:  

• Security Conditions 
• Reduction of threats 
• Testing for Vulnerabilities 
• Testing for Penetration 

The FDA recommends evaluating the SPDF for cybersecurity. In addition to preventing the requirement to completely remake or revamp the device, early testing for security ensures that safety flaws are fixed before impacting the date of release. After release, continuous cybersecurity analysis is conducted following the danger to make sure that flaws may be identified and fixed before they are exploited.  

Ensure FDA-Approved Cybersecurity Now, Get a Free Consultation.

FDA Premarket Submission Requirements

Cybersecurity now plays a major role in FDA premarket submissions for connected medical devices. The level of documentation depends on the device risk, software functionality, and connectivity profile. 

These requirements apply across submission pathways such as:

• 510(k)
• PMA
• De Novo
• HDE
• PDP submissions

Manufacturers may need to submit:

• Threat models
• Security testing results
• SBOM documentation
• Update procedures
• Vulnerability management plans as part of the review process.

FDA Postmarket Cybersecurity Obligations

Continuous Vulnerability Monitoring

New security vulnerabilities appear regularly. Because manufacturers need to keep monitoring CVEs, CISA KEV alerts, and third-party software issues even after the device is released.

Patch Management Expectations

Before releasing a patch, companies need to test it properly. A failed update can affect device performance or disrupt patient care. Rollback procedures are also important in case the update creates new problems. 

Coordinated Vulnerability Disclosure (CVD)

The FDA encourages manufacturers to work with security researchers through coordinated disclosure programs. Many companies use PSIRT teams and follow ISO 29147 and ISO 30111 while handling reported vulnerabilities. 

Incident Reporting Requirements

Some cybersecurity incidents must be reported under MDR rules, especially if they affect patient safety or device functionality. Serious incidents can also lead to recalls or corrective actions. 

What’s New in FDA Cybersecurity Guidelines (Medical Devices) 

For a connected medical device, FDA review now asks a basic question: Can this product stay safe when new security problems appear after launch?

Section 524B applies to “cyber devices,” which means devices that include software, can connect to the internet, and may have features that could be exposed to cybersecurity threats. The rule applies to submissions such as:

• 510(k)
• PMA
• De Novo
• PDP
• HDE

Manufacturers now need to show three things clearly. First, they need a plan for finding and fixing cybersecurity vulnerabilities after the device is on the market. That includes a process for handling reported issues and coordinated vulnerability disclosure.

Second, they need secure development and maintenance processes, along with a way to provide updates and patches when security problems are found. The FDA does not want security treated as a final checklist before submission.

Third, they need to provide an SBOM that lists the commercial, open-source, and off-the-shelf software components inside the device. This gives both the manufacturer and reviewers a clearer view of software supply chain risk.

At a Glance:

Integrating Cybersecurity Into Quality Management Systems (QMS)

Cybersecurity is now closely connected with product quality and safety. Because of this, manufacturers need to include security practices across design controls, CAPA, supplier management, software validation, complaint handling, and risk management processes. 

FDA eSTAR and Technical Screening Requirements

The FDA now checks cybersecurity documents much earlier during submission intake. Missing or incomplete security information can:

• Trigger Technical Screening holds
• Cause Refuse to Accept decisions
• Delay review timelines 

Cybersecurity is no longer treated as an optional review item. FDA eSTAR has become a basic requirement for connected medical device submissions. 

Common FDA Refuse to Accept (RTA) Risks

Many companies run into problems because cybersecurity work starts too late in development. Missing documents and weak security processes can quickly delay FDA reviews. Common issues include:

• Incomplete SBOMs
• Missing threat models
• Unsupported or outdated software libraries
• Weak supplier oversight
• Poor traceability between documents
• No formal PSIRT process
• Weak postmarket governance
• Disconnected QA and cybersecurity teams
• Security testing done only before submission 

The FDA also looks closely at software supply chain management, update mechanisms, and how third-party dependencies are monitored throughout the product lifecycle.

AI/ML Medical Devices and Cybersecurity Risks

AI-Specific Security Risks

AI and ML-based medical devices can face security problems that do not exist in traditional software. Some attacks target the model itself. Others try to manipulate how the system responds to data or user input. Common risks include:

• Model poisoning
• Adversarial attacks
• Prompt injection
• Inference attacks
• Model theft
• Training data manipulation

FDA Concerns Around AI Medical Systems

AI-based medical systems can behave differently over time, which creates extra safety and security concerns. The FDA guidance on AI in medical devices pays close attention to things like:

• Cloud-based inference systems
• Autonomous decision-making
• Continuous learning models
• Software updates that change device behavior

Encryption and Data Protection Requirements

Medical devices handle sensitive patient information. Weak encryption can create serious problems. That is why manufacturers are expected to secure stored data, protect communication channels, and safely manage encryption keys during the device lifecycle.

This usually includes:

• Encryption for stored data
• TLS-secured communication
• VPN protection for remote access
• Certificate management
• Secure key storage

Many companies assume HIPAA compliance is enough, but the FDA looks beyond patient data privacy. The review also focuses on device security, software protection, and patient safety risks.

Best Practices for Medical Device Manufacturers

Cybersecurity works better when it becomes part of daily development instead of a last-minute compliance task. Many manufacturers now use DevSecOps and secure CI CD pipelines so security checks happen throughout development. 

Some practices that help reduce long-term risks include:

• Automated SBOM generation
• Continuous vulnerability monitoring
• Formal vulnerability disclosure programs
• Strong supplier governance policies
• Security testing during every release
• Regular independent penetration testing
• Executive-level cybersecurity oversight

Core Cybersecurity Controls for Connected Medical Devices

To help cybersecurity experts manage healthcare device safety, the FDA developed cybersecurity guidelines for connected medical equipment. When handling medical equipment, important security requirements are satisfied, including:  

• Incorporate safety in the device. 
• Make safety unique to all of them. 
• Firmware security 
• Device-stored secure data 
• Secure connection between devices 

Medical device intrusions can take many different forms, ranging from attacks using ransomware where attackers pretend to have compromised IoMT devices and want payment to restore availability, to theft of information operations that are intended to go undetected. It is essential to continuously monitor for various cybersecurity attacks to identify vulnerabilities before hackers cause significant damage. 

There isn’t any simple method for securing each medical instrument against every type of attack because there are so many variables that affect IoMT safety. Making sure you know which medical equipment is on your computer system and what kinds of attacks could damage them is an essential starting point, though.

How can Healthcare Device Makers Improve their Security? 

Manufacturers of medical devices can improve their cybersecurity by implementing these strategies:

1. Secure Communications: When it involves transmitting information between and within the device, the manufacturer should consider how the gadget might function with different networks and devices, communicate with equipment that provides less secure communication, and guard from unauthorized access or alteration.
2. Data Protection: The manufacturer should determine whether some level of cryptography is necessary for data that is stored or transferred on the device. This also covers whether privacy risk control techniques are necessary for the device.
3. Device integrity: The manufacturer should assess threats to the device’s integrity, examine the system-level framework for mandatory characteristics, as well as anti-malware measures.
4. User Authentication: The creator should consider user identification, which determines who may use the gadget or grant access to user roles.
5. Software Maintenance: The maker ought to take the method of communication into account. This covers the control and updating of the software. Additionally, the connections that are required to perform updates, the method of updating the device to protect it from other weaknesses, and the usage of code signatures to verify the legitimacy of the link.
6. Access Controls: To avoid unauthorized access to the gadget, the maker ought to think about implementing limitations.
7. Durability and Reliability: The manufacturer should consider creating features that enable the gadget to recognize, thwart, react to, and recover from cyberattacks.

Organizations can align their practices with the latest FDA cybersecurity guidance to avoid risks and meet regulatory expectations.

Benefits of Manufacturers Following FDA Standards

The recommendations cover the main responsibilities of manufacturers of medical devices that employ open-source software. The FDA’s Safety Management rule explains these obligations. The FDA has previously notified companies of their responsibilities. 

The purpose of this data is to help manufacturers fully comprehend their cybersecurity responsibilities under the FDA for devices for medical use. If companies decide to use OTS programs, they must take action to maintain the security and functionality of their connected equipment. In addition, the security and functionality of their gadgets are compromised by flaws in OTS technology. 

Medical device manufacturers are required by the FDA’s Quality Framework rule to look into reliable sources of data and address or prevent quality problems. Software patches are typically not subject to FDA review before being installed by a device manufacturer. 

The majority of improvements to the software are regarded by the FDA as design changes that companies are free to implement with no prior FDA approval. In the past, the FDA has advised manufacturers on when to seek advice from the FDA. 

Suppliers are required to verify their software versions under the Quality System rule. This means they have to look at what the change achieves and show that the updated application meets user needs and functions as intended regularly. 

However, it is rarely necessary for manufacturers to request FDA approval for their implants. However, they must create and carry out a strategy for these changes as part of quality control. To safeguard the gadgets and adhere to FDA cybersecurity guidelines for medical devices, companies could request expert assistance from penetration test firms. 

Practical FDA Cybersecurity Implementation Roadmap

Phase 1: Gap Assessment

Start with a simple review of your current security practices. Look at your existing processes and controls. Then compare them with the FDA guidance and Section 524B requirements. This helps uncover missing areas before the submission stage. 

Phase 2: SPDF Integration

The next step is adding security into everyday development work. Security checks should become part of testing and QMS workflows instead of happening only before submission.

Phase 3: Threat Modeling and Architecture Review

In this phase, teams check where attackers might get access. They review exposed areas, trust boundaries, and weak points across the device and connected systems.

Phase 4: SBOM Automation

This phase focuses on automating SBOM creation and software dependency tracking. It helps teams quickly spot outdated libraries, vulnerable components, and third-party software risks during development.

Phase 5: Security Testing

At this stage, teams test how the device behaves under real security attacks and unexpected conditions. This usually includes:

• SAST
• DAST
• Penetration testing
• Fuzz testing
• Exploit validation

Phase 6: Premarket Documentation Preparation

Now the focus shifts to paperwork and evidence collection. Teams gather security test results, risk management records, SBOMs, traceability documents, and other cybersecurity evidence required for FDA review.

Phase 7: Postmarket Monitoring Program

Once the device is on the market, security work continues. Teams need processes for:

• Vulnerability monitoring
• Patch management
• PSIRT operations
• Incident response procedures

Why Medical Device Manufacturers Work With Qualysec

FDA cybersecurity submissions need evidence from real security testing. Qualysec supports this through penetration testing services across web applications, mobile apps, APIs, cloud environments, IoT devices, AI systems, external networks, and source code reviews.

For medical device and healthcare teams, this can help with:

• Web and mobile application penetration testing
• API penetration testing
• Cloud penetration testing
• IoT and healthcare device testing
• Source code review
• Vulnerability assessment and security testing

Qualysec’s healthcare testing page also mentions working around healthcare web applications, mobile apps, device security, secure APIs, and backend services.

The main value is practical: finding security gaps, giving remediation guidance, and helping teams prepare stronger technical evidence before submission or release. 

Speak Directly With Qualysec’s Certified Security Experts

Discover vulnerabilities before attackers exploit them

Schedule Free Consultation →

Conclusion 

With more and more companies depending on smart devices or the World Wide Web of Medical Equipment, the healthcare industry is changing. IoMT offers innovative ways to modernize medical practices and enhance patient treatment, but it isn’t risk-free. These gadgets are vulnerable to potential cyberattacks since they don’t have sufficient safety features in place. To address this, aligning with FDA Cybersecurity Guidelines can help identify possible security dangers and vulnerabilities to ensure comprehensive protection. Once we are aware of our difficulties, we can implement efficient safeguards.

The system at hand may function more securely if the threat surface, the sum of all possible security issues, is managed. In addition, as technology develops, protecting patient information and electronic medical records becomes increasingly important.  Medical device cybersecurity is now part of the safety case a manufacturer presents to the FDA. The agency’s latest guidance links security with device design, labeling, quality processes, and premarket documentation, while Section 524B adds specific requirements for cyber devices, including SBOMs, postmarket updates, patches, and vulnerability handling.

Regarding medical device safety, we must speak with an expert. QualySec Technologies, a reputable business, offers healthcare vulnerability and penetration testing services. At QualySec Technologies, we understand how important it is to protect client data and healthcare systems. Our specialized healthcare penetration testing services aim to identify potential weaknesses in your healthcare devices, software, and networks beforehand.  

Do not wait for a security compromise to jeopardize patients’ health and confidence. Contact QualySec Technologies right now to arrange a comprehensive healthcare security assessment tailored to your company’s unique needs. Let’s work together to bolster our protections and give everyone access to a safe and effective medical ecosystem. 

FAQ: 

1. What is medical device cyber security?  

The practices and tools HDOs employ to protect their Internet of Medical Things (IoMT) are referred to as medical device security measures. Additionally, it protects medical software and devices from unauthorized access, theft of information, threats to patient safety, and/or disruptions of essential services.  

2. What is a medical device that is networked?  

Medical devices with networks include heart rate monitors, pumps for infusion, and imaging diagnostic equipment. These devices may be utilized to track patients, transfer patient data, and/or offer treatment.  

3. Why is cybersecurity crucial for medical machinery?  

Medical gear is protected by cybersecurity against malevolent thieves who could gain access to the device and alter data. In addition, this may result in financial damage, breach of confidentiality, or interruptions in care. 

4. What Is a Cyber Device Under FDA Rules?

A cyber device is a medical device that has software, can connect to the internet, and has technology that may be exposed to cybersecurity threats. The FDA applies Section 524B to these devices across 510(k), PMA, De Novo, PDP, and HDE submissions.

5. What Is an SBOM in FDA Cybersecurity Compliance?

An SBOM is the software ingredient list for a medical device. It records commercial, open-source, and off-the-shelf components used in the product. FDA requires it for cyber devices so manufacturers can trace affected parts when a new vulnerability appears.

6. Does the FDA Require Penetration Testing for Medical Devices?

FDA guidance does not frame penetration testing as the only required test for every device. It expects security testing based on the device’s risk and design. For connected devices, penetration testing can give strong proof that real attack paths were checked.

7. How Has Medical Device Cybersecurity Become a Patient Safety Issue?

Connected devices now support treatment, monitoring, diagnosis, and clinical decisions. A cyber weakness can affect device availability, data accuracy, or safe operation. FDA guidance treats cybersecurity as part of device safety and the quality system, not only an IT concern.

8. How Can Healthcare Organizations Secure Legacy Medical Devices?

Legacy devices often run older software and may not support modern security updates. Hospitals can reduce risk through device inventory, network separation, restricted remote access, traffic monitoring, vendor communication, and replacement planning for devices that can no longer be safely maintained.

9. How Can Vendors and Healthcare Providers Coordinate Medical Device Security?

Vendors should give clear security contacts, patch instructions, disclosure channels, and support timelines. Healthcare providers should report unusual device behavior, apply approved updates, restrict access, and share environment details when needed. FDA postmarket guidance encourages security work across deployment and maintenance.

10. What Happens if a Medical Device Fails FDA Cybersecurity Review?

If cybersecurity information is missing or weak, FDA review can slow down or face intake problems. The sponsor may need to add testing evidence, improve the SBOM, explain patch plans, fix security gaps, or clarify how postmarket vulnerabilities will be handled.

Ensure your healthcare solution is globally compliant.
Qualysec helps you meet HIPAA, FDA, ISO, and more. Contact us today!